Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation
Nadia Zakaria(Novartis (Switzerland)), Marie‐José Tassignon(University of Antwerp)
Cited by 111
Related Papers
Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies
|Stem Cells International|2015|179
Pterygium Pathology: A Prospective Case-Control Study on Tear Film Cytokine Levels
|Mediators of Inflammation|2019|23